Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Given Consensus Rating of “Hold” by Brokerages

Carl Zeiss Meditec AG (OTCMKTS:CZMWY) has been assigned an average recommendation of “Hold” from the six ratings firms that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the company.

Several brokerages recently weighed in on CZMWY. The Goldman Sachs Group cut shares of Carl Zeiss Meditec from a “buy” rating to a “neutral” rating in a report on Tuesday, January 20th. Sanford C. Bernstein cut shares of Carl Zeiss Meditec to a “market perform” rating in a report on Monday, January 26th.

Carl Zeiss Meditec Trading Up 1.8%

Shares of CZMWY opened at $27.32 on Tuesday. Carl Zeiss Meditec has a 1 year low of $26.85 and a 1 year high of $76.28. The stock has a 50-day simple moving average of $35.05 and a 200-day simple moving average of $44.91.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.